{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T07:13:27Z","timestamp":1789456407778,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Hospital"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To investigate the prevalence and clinical characteristics of Charles Bonnet Syndrome (CBS) in patients referred for bilateral cataract surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This prospective, cross-sectional clinical trial included 391 patients attending cataract assessment at a single-center tertiary cataract clinic. After clinical examination, participants were screened for presence of visual hallucinations (VHs). Participants experiencing complex VHs were further questioned regarding characteristics of their hallucinatory experiences to properly determine if they were attributable to CBS. CBS was defined as complex visual hallucinations with retained insight, no medical history or medication known to cause hallucinations and not limited to hypnagogic or hypnopompic states (hallucinations happening shortly before falling asleep and\/or shortly after waking up).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Nineteen (4.9%) patients experienced complex VHs. Of these, 11 (2.8%) were diagnosed with CBS while 8 (2.1%) had complex hypnagogic and\/or hypnopompic VHs. Multivariable logistic regression analysis identified lower best-corrected visual acuity (BCVA) in the better seeing eye as\u00a0a significant predictor of CBS. When excluding participants with a BCVA&gt;0.3, prevalence of complex VHs rose to 10.0%. Three of the patients with CBS (27.3%) had ocular comorbidities: two had exudative age-related macular degeneration (AMD), and one had drusenoid AMD. In the overall cohort, twenty-four patients (6.1%) reported prior knowledge of CBS.\u00a0<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>CBS was observed in a clinically relevant minority of cataract patients requiring bilateral surgical intervention. Given the high prevalence of cataract among the elderly, this study highlights the importance of healthcare personnel being aware of CBS and other complex VHs and their potential consequences for cataract patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00417-026-07241-0","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T04:20:25Z","timestamp":1776831625000},"page":"2783-2793","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Charles Bonnet syndrome in patients referred for cataract surgery"],"prefix":"10.1007","volume":"264","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0979-1316","authenticated-orcid":false,"given":"Mads Assenholt","family":"Nielsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6620-6242","authenticated-orcid":false,"given":"Jakob","family":"Bjerager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fclsenay","family":"Citirak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6620-5365","authenticated-orcid":false,"given":"Yousif","family":"Subhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1782-7456","authenticated-orcid":false,"given":"Lars Morten","family":"Holm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1955-4081","authenticated-orcid":false,"given":"Amardeep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"7241_CR1","first-page":"678","volume":"2","author":"G de Morsier","year":"1967","unstructured":"de Morsier G (1967) The Charles Bonnet syndrome: visual hallucinations in the aged without mental deficiency. Ann Med Psychol (Paris) 2:678\u2013702","journal-title":"Ann Med Psychol (Paris)"},{"key":"7241_CR2","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/S0039-6257(02)00414-9","volume":"48","author":"GJ Menon","year":"2003","unstructured":"Menon GJ, Rahman I, Menon SJ, Dutton GN (2003) Complex visual hallucinations in the visually impaired. Surv Ophthalmol 48:58\u201372. https:\/\/doi.org\/10.1016\/S0039-6257(02)00414-9","journal-title":"Surv Ophthalmol"},{"key":"7241_CR3","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1136\/jnnp-2019-322702","volume":"91","author":"J O\u2019Brien","year":"2020","unstructured":"O\u2019Brien J, Taylor JP, Ballard C et al (2020) Visual hallucinations in neurological and ophthalmological disease: pathophysiology and management. J Neurol Neurosurg Psychiatry 91:512\u2013519. https:\/\/doi.org\/10.1136\/jnnp-2019-322702","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7241_CR4","first-page":"47","volume":"173","author":"A Singh","year":"2010","unstructured":"Singh A, S\u00f8rensen TL (2010) Charles Bonnet Syndrom og visuelle hallucinationer. Ugeskr Laeg 173:47\u201349","journal-title":"Ugeskr Laeg"},{"key":"7241_CR5","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1136\/bjophthalmol-2014-304920","volume":"98","author":"TM Cox","year":"2014","unstructured":"Cox TM, Ffytche DH (2014) Negative outcome Charles Bonnet syndrome. Br J Ophthalmol 98:1236\u20131239. https:\/\/doi.org\/10.1136\/bjophthalmol-2014-304920","journal-title":"Br J Ophthalmol"},{"key":"7241_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.21037\/aes-21-37","volume":"7","author":"Y Subhi","year":"2022","unstructured":"Subhi Y, Nielsen MA, Scott DAR et al (2022) Prevalence of Charles Bonnet syndrome in low vision: a systematic review and meta-analysis. Ann Eye Sci 7:12\u201312. https:\/\/doi.org\/10.21037\/aes-21-37","journal-title":"Ann Eye Sci"},{"key":"7241_CR7","doi-asserted-by":"publisher","DOI":"10.1177\/25158414241305500","volume":"17","author":"NS Eriksen","year":"2025","unstructured":"Eriksen NS, Mousavi N, Subhi Y et al (2025) Charles Bonnet syndrome in patients with geographic atrophy secondary to age-related macular degeneration: a cross-sectional study. Ther Adv Ophthalmol 17:25158414241305500. https:\/\/doi.org\/10.1177\/25158414241305500","journal-title":"Ther Adv Ophthalmol"},{"key":"7241_CR8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/aos.14287","volume":"98","author":"S Niazi","year":"2020","unstructured":"Niazi S, Krogh Nielsen M, Singh A et al (2020) Prevalence of Charles Bonnet syndrome in patients with age-related macular degeneration: systematic review and meta\u2010analysis. Acta Ophthalmol (Copenh) 98:121\u2013131. https:\/\/doi.org\/10.1111\/aos.14287","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"7241_CR9","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/aos.14567","volume":"99","author":"Y Subhi","year":"2021","unstructured":"Subhi Y, Schmidt DC, Bach-Holm D et al (2021) Prevalence of Charles Bonnet syndrome in patients with glaucoma: a systematic review with meta\u2010analyses. Acta Ophthalmol (Copenh) 99:128\u2013133. https:\/\/doi.org\/10.1111\/aos.14567","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"7241_CR10","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ogla.2021.10.010","volume":"5","author":"D Peters","year":"2022","unstructured":"Peters D, Molander S, Lomo T, Singh A (2022) Charles bonnet syndrome in patients with open-angle glaucoma. Ophthalmol Glaucoma 5:337\u2013344. https:\/\/doi.org\/10.1016\/j.ogla.2021.10.010","journal-title":"Ophthalmol Glaucoma"},{"key":"7241_CR11","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ogla.2023.07.001","volume":"7","author":"P Randeblad","year":"2024","unstructured":"Randeblad P, Singh A, Peters D (2024) Charles bonnet syndrome adversely affects vision-related quality of life in patients with glaucoma. Ophthalmol Glaucoma 7:30\u201336. https:\/\/doi.org\/10.1016\/j.ogla.2023.07.001","journal-title":"Ophthalmol Glaucoma"},{"key":"7241_CR12","doi-asserted-by":"publisher","first-page":"122","DOI":"10.24869\/psyd.2018.122","volume":"30","author":"D Juri\u0161i\u0107","year":"2018","unstructured":"Juri\u0161i\u0107 D, Sesar I, \u0106avar I et al (2018) Hallucinatory experiences in visually impaired individuals: Charles Bonnet syndrome - implications for research and clinical practice. Psychiatr Danub 30:122\u2013128. https:\/\/doi.org\/10.24869\/psyd.2018.122","journal-title":"Psychiatr Danub"},{"key":"7241_CR13","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1016\/j.ophtha.2015.03.006","volume":"122","author":"F O\u2019Hare","year":"2015","unstructured":"O\u2019Hare F, Bentley SA, Wu Z et al (2015) Charles bonnet syndrome in advanced retinitis pigmentosa. Ophthalmology 122:1951\u20131953. https:\/\/doi.org\/10.1016\/j.ophtha.2015.03.006","journal-title":"Ophthalmology"},{"key":"7241_CR14","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1136\/bjophthalmol-2021-319525","volume":"107","author":"PPA Dhooge","year":"2023","unstructured":"Dhooge PPA, Teunisse RJ, Liefers B et al (2023) Charles bonnet syndrome in patients with Stargardt disease: prevalence and risk factors. Br J Ophthalmol 107:248\u2013253. https:\/\/doi.org\/10.1136\/bjophthalmol-2021-319525","journal-title":"Br J Ophthalmol"},{"key":"7241_CR15","doi-asserted-by":"publisher","first-page":"182","DOI":"10.5694\/mja2.51421","volume":"216","author":"H Birrell","year":"2022","unstructured":"Birrell H, Tang K (2022) An atypical case of Charles bonnet syndrome secondary to advanced cataracts. Med J Aust 216:182\u2013183. https:\/\/doi.org\/10.5694\/mja2.51421","journal-title":"Med J Aust"},{"key":"7241_CR16","doi-asserted-by":"publisher","first-page":"e283","DOI":"10.1097\/WNO.0000000000001432","volume":"43","author":"RS Rosenberg","year":"2023","unstructured":"Rosenberg RS, Gupta K (2023) Text on the walls: an unusual case of Charles bonnet syndrome in a patient with cataracts. J Neuroophthalmol 43:e283\u2013e284. https:\/\/doi.org\/10.1097\/WNO.0000000000001432","journal-title":"J Neuroophthalmol"},{"key":"7241_CR17","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.16801","author":"FJ Somoza-Cano","year":"2021","unstructured":"Somoza-Cano FJ, Abuyakoub A, Hammad F et al (2021) Nonpsychotic Hallucinations and Impaired Vision: The Charles Bonnet Syndrome. Cureus. https:\/\/doi.org\/10.7759\/cureus.16801","journal-title":"Cureus"},{"key":"7241_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jcjo.2015.10.006","volume":"51","author":"KD Gordon","year":"2016","unstructured":"Gordon KD (2016) Prevalence of visual hallucinations in a national low vision client population. Can J Ophthalmol 51:3\u20136. https:\/\/doi.org\/10.1016\/j.jcjo.2015.10.006","journal-title":"Can J Ophthalmol"},{"key":"7241_CR19","doi-asserted-by":"publisher","first-page":"30","DOI":"10.21037\/aes-20-115","volume":"5","author":"S Molander","year":"2020","unstructured":"Molander S, Peters D, Singh A (2020) Charles Bonnet syndrome: low awareness among patients with glaucoma. Ann Eye Sci 5:30\u201330. https:\/\/doi.org\/10.21037\/aes-20-115","journal-title":"Ann Eye Sci"},{"key":"7241_CR20","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/j.1755-3768.2010.02051.x","volume":"90","author":"A Singh","year":"2012","unstructured":"Singh A, S\u00f8rensen TL (2012) The prevalence and clinical characteristics of Charles Bonnet syndrome in Danish patients with neovascular age-related macular degeneration. Acta Ophthalmol (Copenh) 90:476\u2013480. https:\/\/doi.org\/10.1111\/j.1755-3768.2010.02051.x","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"7241_CR21","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/aos.16785","volume":"103","author":"MA Nielsen","year":"2025","unstructured":"Nielsen MA, Bjerager J, Citirak G et al (2025) Patient-reported visual function outcomes in immediately sequential versus delayed sequential bilateral cataract surgery. Acta Ophthalmol (Copenh) 103:339\u2013347. https:\/\/doi.org\/10.1111\/aos.16785","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"7241_CR22","unstructured":"Sundhedsstyrrelsen (2020) National klinisk retningslinje for behandling af aldersbetinget gr\u00e5 staer"},{"key":"7241_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-019-0582-1","volume":"21","author":"AG Hamedani","year":"2019","unstructured":"Hamedani AG, Pelak VS (2019) The Charles Bonnet syndrome: a systematic review of diagnostic criteria. Curr Treat Options Neurol 21:41. https:\/\/doi.org\/10.1007\/s11940-019-0582-1","journal-title":"Curr Treat Options Neurol"},{"key":"7241_CR24","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1167\/iovs.06-0942","volume":"48","author":"EJ Abbott","year":"2007","unstructured":"Abbott EJ, Connor GB, Artes PH, Abadi RV (2007) Visual loss and visual hallucinations in patients with age-related macular degeneration (Charles Bonnet Syndrome). Invest Ophthalmol Vis Sci 48:1416. https:\/\/doi.org\/10.1167\/iovs.06-0942","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"7241_CR25","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1007\/s00417-016-3387-x","volume":"254","author":"HM Elflein","year":"2016","unstructured":"Elflein HM, Rudy M, Lorenz K et al (2016) Charles Bonnet\u2019s syndrome: not only a condition of the elderly. Graefes Arch Clin Exp Ophthalmol 254:1637\u20131642. https:\/\/doi.org\/10.1007\/s00417-016-3387-x","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"7241_CR26","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1176\/ajp.149.12.1701","volume":"149","author":"S Holroyd","year":"1992","unstructured":"Holroyd S (1992) Visual hallucinations in patients with macular degeneration. Am J Psychiatry 149:1701\u20131706. https:\/\/doi.org\/10.1176\/ajp.149.12.1701","journal-title":"Am J Psychiatry"},{"key":"7241_CR27","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1167\/iovs.12-11091","volume":"54","author":"AM Hanneken","year":"2013","unstructured":"Hanneken AM, Babai N, Thoreson WB (2013) Oral proton pump inhibitors disrupt horizontal cell-cone feedback and enhance visual hallucinations in macular degeneration patients. Invest Ophthalmol Vis Sci 54:1485. https:\/\/doi.org\/10.1167\/iovs.12-11091","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"7241_CR28","doi-asserted-by":"publisher","first-page":"4138","DOI":"10.1167\/iovs.16-21270","volume":"58","author":"JE Leandro","year":"2017","unstructured":"Leandro JE, Beato J, Pedrosa AC et al (2017) The Charles bonnet syndrome in patients with neovascular age-related macular degeneration: association with proton pump inhibitors. Invest Ophthalmol Vis Sci 58:4138. https:\/\/doi.org\/10.1167\/iovs.16-21270","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"7241_CR29","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1192\/bjp.166.2.254","volume":"166","author":"RJ Teunisse","year":"1995","unstructured":"Teunisse RJ, Cruysberg JRM, Verbeek A, Zitman FG (1995) The Charles bonnet syndrome: a large prospective study in the Netherlands: a study of the prevalence of the Charles bonnet syndrome and associated factors in 500 patients attending the University Department of Ophthalmology at Nijmegen. Br J Psychiatry 166:254\u2013257. https:\/\/doi.org\/10.1192\/bjp.166.2.254","journal-title":"Br J Psychiatry"},{"key":"7241_CR30","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3129\/i08-169","volume":"44","author":"G Gilmour","year":"2009","unstructured":"Gilmour G, Schreiber C, Ewing C (2009) An examination of the relationship between low vision and Charles bonnet syndrome. Can J Ophthalmol 44:49\u201352. https:\/\/doi.org\/10.3129\/i08-169","journal-title":"Can J Ophthalmol"},{"key":"7241_CR31","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1136\/bjo.2004.041947","volume":"88","author":"CSH Tan","year":"2004","unstructured":"Tan CSH (2004) Charles bonnet syndrome in Asian patients in a tertiary ophthalmic centre. Br J Ophthalmol 88:1325\u20131329. https:\/\/doi.org\/10.1136\/bjo.2004.041947","journal-title":"Br J Ophthalmol"},{"key":"7241_CR32","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1093\/fampra\/cmy006","volume":"35","author":"KD Gordon","year":"2018","unstructured":"Gordon KD, Felfeli T (2018) Family physician awareness of Charles bonnet syndrome. Fam Pract 35:595\u2013598. https:\/\/doi.org\/10.1093\/fampra\/cmy006","journal-title":"Fam Pract"},{"key":"7241_CR33","volume":"61","author":"A Singh","year":"2014","unstructured":"Singh A, Subhi Y, S\u00f8rensen TL (2014) Low awareness of the Charles bonnet syndrome in patients attending a retinal clinic. Dan Med J 61:A4770","journal-title":"Dan Med J"},{"key":"7241_CR34","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1136\/bjo.2010.179465","volume":"95","author":"A Singh","year":"2011","unstructured":"Singh A, Sorensen TL (2011) Charles Bonnet syndrome improves when treatment is effective in age-related macular degeneration. Br J Ophthalmol 95:291\u2013292. https:\/\/doi.org\/10.1136\/bjo.2010.179465","journal-title":"Br J Ophthalmol"},{"key":"7241_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2025.111282","volume":"223","author":"SEG Christoph","year":"2025","unstructured":"Christoph SEG, Boden KT, Siegel R et al (2025) The prevalence of Charles-Bonnet syndrome in ophthalmic patients: a systematic review and meta-analysis. Brain Res Bull 223:111282. https:\/\/doi.org\/10.1016\/j.brainresbull.2025.111282","journal-title":"Brain Res Bull"},{"key":"7241_CR36","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.genhosppsych.2012.05.007","volume":"34","author":"Y Hou","year":"2012","unstructured":"Hou Y, Zhang Y (2012) The prevalence and clinical characteristics of Charles Bonnet syndrome in Chinese patients. Gen Hosp Psychiatry 34:566\u2013570. https:\/\/doi.org\/10.1016\/j.genhosppsych.2012.05.007","journal-title":"Gen Hosp Psychiatry"},{"key":"7241_CR37","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1080\/09286580801939320","volume":"15","author":"JC Khan","year":"2008","unstructured":"Khan JC, Shahid H, Thurlby DA et al (2008) Charles Bonnet syndrome in age-related macular degeneration: the nature and frequency of images in subjects with end-stage disease. Ophthalmic Epidemiol 15:202\u2013208. https:\/\/doi.org\/10.1080\/09286580801939320","journal-title":"Ophthalmic Epidemiol"},{"key":"7241_CR38","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/j.1442-9071.2008.01814.x","volume":"36","author":"M Vukicevic","year":"2008","unstructured":"Vukicevic M, Fitzmaurice K (2008) Butterflies and black lacy patterns: the prevalence and characteristics of Charles Bonnet hallucinations in an Australian population. Clin Exp Ophthalmol 36:659\u2013665. https:\/\/doi.org\/10.1111\/j.1442-9071.2008.01814.x","journal-title":"Clin Exp Ophthalmol"},{"key":"7241_CR39","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1136\/jnnp.73.5.535","volume":"73","author":"W Burke","year":"2002","unstructured":"Burke W (2002) The neural basis of Charles Bonnet hallucinations: a hypothesis. J Neurol Neurosurg Psychiatry 73:535\u2013541. https:\/\/doi.org\/10.1136\/jnnp.73.5.535","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7241_CR40","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/opo.12645","volume":"39","author":"K Carpenter","year":"2019","unstructured":"Carpenter K, Jolly JK, Bridge H (2019) The elephant in the room: understanding the pathogenesis of Charles Bonnet syndrome. Ophthalmic Physiol Opt 39:414\u2013421. https:\/\/doi.org\/10.1111\/opo.12645","journal-title":"Ophthalmic Physiol Opt"},{"key":"7241_CR41","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1097\/OPX.0000000000000959","volume":"93","author":"L Pang","year":"2016","unstructured":"Pang L (2016) Hallucinations experienced by visually impaired: Charles Bonnet syndrome. Optom Vis Sci Off Publ Am Acad Optom 93:1466\u20131478. https:\/\/doi.org\/10.1097\/OPX.0000000000000959","journal-title":"Optom Vis Sci Off Publ Am Acad Optom"},{"issue":"8941","key":"7241_CR42","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/S0140-6736(95)91198-7","volume":"345","author":"R Howard","year":"1995","unstructured":"Howard R, Williams S, Bullmore E et al (1995) Cortical response to exogenous visual stimulation during visual hallucinations. Lancet 345:70. https:\/\/doi.org\/10.1016\/S0140-6736(95)91198-7","journal-title":"Lancet"},{"key":"7241_CR43","doi-asserted-by":"publisher","DOI":"10.1177\/25158414241280201","volume":"16","author":"H Bridge","year":"2024","unstructured":"Bridge H, Wyllie A, Kay A et al (2024) Neurochemistry and functional connectivity in the brain of people with Charles Bonnet syndrome. Ther Adv Ophthalmol 16:25158414241280201. https:\/\/doi.org\/10.1177\/25158414241280201","journal-title":"Ther Adv Ophthalmol"},{"key":"7241_CR44","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/eye.1993.14","volume":"7","author":"NAP Brown","year":"1993","unstructured":"Brown NAP (1993) The morphology of cataract and visual performance. Eye 7:63\u201367. https:\/\/doi.org\/10.1038\/eye.1993.14","journal-title":"Eye"},{"key":"7241_CR45","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1475-1313.1989.tb00800.x","volume":"9","author":"DB Elliott","year":"1989","unstructured":"Elliott DB, Gilchrist J, Whitaker D (1989) Contrast sensitivity and glare sensitivity changes with three types of cataract morphology: are these techniques necessary in a clinical evaluation of cataract? Ophthalmic Physiol Opt 9:25\u201330. https:\/\/doi.org\/10.1111\/j.1475-1313.1989.tb00800.x","journal-title":"Ophthalmic Physiol Opt"},{"key":"7241_CR46","doi-asserted-by":"publisher","unstructured":"Albqaeen W, Davies AC, Shim G (2025) It Is All One-Sided: Monocular Blindness and Charles Bonnet Syndrome. Cureus. https:\/\/doi.org\/10.7759\/cureus.92148","DOI":"10.7759\/cureus.92148"},{"key":"7241_CR47","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1136\/bjo.2006.104604","volume":"91","author":"ML Jackson","year":"2007","unstructured":"Jackson ML, Bassett K, Nirmalan PV, Sayre EC (2007) Contrast sensitivity and visual hallucinations in patients referred to a low vision rehabilitation clinic. Br J Ophthalmol 91:296\u2013298. https:\/\/doi.org\/10.1136\/bjo.2006.104604","journal-title":"Br J Ophthalmol"},{"key":"7241_CR48","first-page":"26","volume":"6","author":"JH Shandiz","year":"2011","unstructured":"Shandiz JH, Derakhshan A, Daneshyar A et al (2011) Effect of cataract type and severity on visual acuity and contrast sensitivity. J Ophthalmic Vis Res 6:26\u201331","journal-title":"J Ophthalmic Vis Res"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07241-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-026-07241-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07241-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:53:33Z","timestamp":1789455213000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-026-07241-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":48,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["7241"],"URL":"https:\/\/doi.org\/10.1007\/s00417-026-07241-0","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"11 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and its later amendments. All participants provided written informed consent prior to inclusion. According to Danish regulations, this observational study did not require approval from a regional ethics committee.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Clinical trial number: not applicable.","order":2,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}